Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes

BACKGROUND: Immunotherapy with immune checkpoint inhibitors (ICIs) is highly effective in microsatellite instability–high (MSI‐H) metastatic colorectal cancer (mCRC); however, specific predictive biomarkers are lacking. PATIENTS AND METHODS: Data and samples from 85 patients with MSI‐H mCRC treated...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Oncologist
Egile Nagusiak: Loupakis, Fotios, Depetris, Ilaria, Biason, Paola, Intini, Rossana, Prete, Alessandra Anna, Leone, Francesco, Lombardi, Pasquale, Filippi, Roberto, Spallanzani, Andrea, Cascinu, Stefano, Bonetti, Luca Reggiani, Maddalena, Giulia, Valeri, Nicola, Sottoriva, Andrea, Zapata, Luis, Salmaso, Roberta, Munari, Giada, Rugge, Massimo, Dei Tos, Angelo Paolo, Golovato, Justin, Sanborn, John Z., Nguyen, Andrew, Schirripa, Marta, Zagonel, Vittorina, Lonardi, Sara, Fassan, Matteo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley & Sons, Inc. 2020
Gaiak:
Gastrointestinal Cancer
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7288636/
https://ncbi.nlm.nih.gov/pubmed/31967692
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0611
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak